Literature DB >> 21928062

Contrast agent derived determination of the total circulating blood volume using magnetic resonance.

Kerstin Pannek1, Florian Fidler, Ralf Kartäusch, Peter M Jakob, Karl-Heinz Hiller.   

Abstract

OBJECT: Knowledge of the total circulating blood volume (TCBV) is essential for the treatment of a variety of medical conditions and blood disorders. To date, blood volume analysis is rarely carried out due to the disadvantages of available methods. Our aim was to develop a widely available, simple, fast, yet accurate method for the determination of the total circulating blood volume.
MATERIALS AND METHODS: Magnetic resonance (MR) is a well-established, non-invasive technique. In this article, we present a method that uses MR contrast agents for the determination of the blood volume. The dependence of MR relaxation times on the concentration of MR contrast agents allows the calculation of the volume the contrast agent has been diluted in.
RESULTS: In phantom and in vivo experiments we could demonstrate that TCBV can be determined with high accuracy and precision.
CONCLUSION: This work introduces a novel method for the determination of the total circulating blood volume using magnetic resonance contrast agents as tracers.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21928062     DOI: 10.1007/s10334-011-0282-7

Source DB:  PubMed          Journal:  MAGMA        ISSN: 0968-5243            Impact factor:   2.310


  23 in total

1.  The relative volumes of distribution of I131-tagged albumin and high molecular weight dextran in normal subjects and patients with heart disease.

Authors:  J R JAENIKE; B F SCHREINER; C WATERHOUSE
Journal:  J Lab Clin Med       Date:  1957-02

2.  Fast high-resolution T1 mapping of the human brain.

Authors:  Ralf Deichmann
Journal:  Magn Reson Med       Date:  2005-07       Impact factor: 4.668

3.  Inversion recovery snapshot FLASH MR imaging.

Authors:  A Haase; D Matthaei; R Bartkowski; E Dühmke; D Leibfritz
Journal:  J Comput Assist Tomogr       Date:  1989 Nov-Dec       Impact factor: 1.826

4.  The interaction of MS-325 with human serum albumin and its effect on proton relaxation rates.

Authors:  Peter Caravan; Normand J Cloutier; Matthew T Greenfield; Sarah A McDermid; Stephen U Dunham; Jeff W M Bulte; John C Amedio; Richard J Looby; Ronald M Supkowski; William DeW Horrocks; Thomas J McMurry; Randall B Lauffer
Journal:  J Am Chem Soc       Date:  2002-03-27       Impact factor: 15.419

5.  Vascular capacity and hematocrit in experimental cardiomegaly due to aortic constriction in rats.

Authors:  K Rakusan
Journal:  Can J Physiol Pharmacol       Date:  1971-09       Impact factor: 2.273

6.  Interpretation of measured red cell mass and plasma volume in adults: Expert Panel on Radionuclides of the International Council for Standardization in Haematology.

Authors:  T C Pearson; D L Guthrie; J Simpson; S Chinn; G Barosi; A Ferrant; S M Lewis; Y Najean
Journal:  Br J Haematol       Date:  1995-04       Impact factor: 6.998

7.  Hemodilution is common in patients with advanced heart failure.

Authors:  Ana-Silvia Androne; Stuart D Katz; Lars Lund; John LaManca; Alhakam Hudaihed; Katarzyna Hryniewicz; Donna M Mancini
Journal:  Circulation       Date:  2003-01-21       Impact factor: 29.690

8.  Determination of blood volume using indocyanine green (cardio-green) dye.

Authors:  E C Bradley; J W Barr
Journal:  Life Sci       Date:  1968-09-01       Impact factor: 5.037

9.  Relaxivity of Gadopentetate Dimeglumine (Magnevist), Gadobutrol (Gadovist), and Gadobenate Dimeglumine (MultiHance) in human blood plasma at 0.2, 1.5, and 3 Tesla.

Authors:  Jörg Pintaske; Petros Martirosian; Hansjörg Graf; Gunter Erb; Klaus-Peter Lodemann; Claus D Claussen; Fritz Schick
Journal:  Invest Radiol       Date:  2006-03       Impact factor: 6.016

10.  Blood volume in the rat.

Authors:  H B Lee; M D Blaufox
Journal:  J Nucl Med       Date:  1985-01       Impact factor: 10.057

View more
  1 in total

1.  Blood volume measurement using cardiovascular magnetic resonance and ferumoxytol: preclinical validation.

Authors:  Rajiv Ramasawmy; Toby Rogers; Miguel A Alcantar; Delaney R McGuirt; Jaffar M Khan; Peter Kellman; Hui Xue; Anthony Z Faranesh; Adrienne E Campbell-Washburn; Robert J Lederman; Daniel A Herzka
Journal:  J Cardiovasc Magn Reson       Date:  2018-09-10       Impact factor: 5.364

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.